09,11,2026 7 views
Technological innovation driven by regulation——
Unlocking a New Paradigm for Microfluidic Drug Discovery through the Power of Industry University Research Collaboration
Currently, FDA, EMA, CDE and other institutions are promoting the reduction of animal experiments and accelerating the adoption of more predictive alternative models such as organoids and organ chips, injecting strong impetus into drug development innovation. Under this trend, microfluidic technology - a core technology based on micrometer scale channels for precise fluid manipulation - is becoming a "breakthrough" in the fields of drug discovery, toxicology evaluation, and cell analysis due to its natural advantages of high throughput, low sample consumption, and high biomimicry. Its industry value and application potential are increasingly prominent.
The resonance between technological trends and regulatory guidance is urgent, and it is necessary to establish an industry university research docking platform that connects international frontiers with domestic practices. On December 4th, the online international seminar on "Microfluidic Technology: Driving the Innovation Path of Drug Discovery and Screening" is about to kick off. With the core intention of "empowering industry innovation and promoting resource linkage", we have invited academician level academic strength and world enterprise teams to bring the triple empowerment of "technology+practice+trend" to domestic universities, research institutes, and biopharmaceutical practitioners.
Event Information
This event brings together multiple core forces: Professor Xueqin, President of Biomedical Engineering at The Chinese University of Hong Kong (Shenzhen), Professor Li Chenzhong, Academician of the Canadian Academy of Engineering and National Inventor of the United States, leading the academic field, expert teams from international companies such as Microfluidic ChipShop in Germany, Elveflow in France, and Opto GmbH in Germany sharing industry practical experience, and practical technical experts in the field of microfluidics in China directly addressing industry pain points.
Through the dual wheel drive of "academic+practical", we assist domestic practitioners in keeping up with regulatory and technological trends, aligning with international cutting-edge perspectives, drawing on mature scientific research insights and industrialization experience, clarifying innovation directions, and addressing obstacles in the transformation of industry, academia, and research.
Whether you are a scholar deeply engaged in scientific research, an entrepreneur laying out innovation, or a technician exploring breakthroughs, you can gain insights into regulatory trends, cutting-edge technological experience, and international cooperation opportunities here, and explore the innovative path of empowering drug research and development with flow control technology. Let's gather in the cloud and join forces for this regulatory driven feast of industry university research integration!
✅ Topic: Microfluidic Technology: The Innovative Path Driving Drug Discovery and Screening
✅ Time: December 4, 2025 (Thursday) 14:00-17:00
✅ Location: Online seminar, scan the code at the end of the article to make an appointment for participation
speaker
participation value
✅ Systematic cognitive construction: from chip design to imaging analysis, covering the innovative logic and practical experience of microfluidic technology in the entire process of drug development
✅ Integration of International Perspectives: Bringing together research institutions and business experts from China, Germany, and France to share cutting-edge regulatory trends and technological routes
✅ Dual empowerment of production and research: Combining cutting-edge academic research with industry implementation cases, providing reusable experimental strategies for universities, pharmaceutical companies, and medical device enterprises
✅ High level communication platform: real-time interaction with industry experts, expanding scientific research cooperation and technology transformation network
Suitable for attendees
✅ Scientists and project managers engaged in drug discovery, toxicology assessment, and screening platform construction in pharmaceutical/biotech research and development institutions
✅ PI, postdoctoral, and graduate students engaged in organ chips, microfluidics, oncology, neuroscience, and other fields in universities and research institutes
✅ Research and translational scientists from clinical translational medicine centers, precision medicine laboratories, and IVD companies
